mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |